ACTRN12609000505202已完成不适用
A phase 1 study in healthy volunteers to determine the dermatopharmacokinetics of topically applied diclofenac in combination with the novel penetration enhancer Tocopheryl Phosphate Mixture (TPM), compared with Votaren (registered trademark) gel
Phosphagenics Limited0 个研究点目标入组 24 人开始时间: 2009年6月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Healthy males and females aged 18 to 55 years inclusive.
排除标准
- •Pregnant or breast-feeding, skin conditions preventing gel application, current clinically significant medical conditions, on chronic medications, on medications which may interact with non-steroidal anti-inflamatory drugs
研究者
相似试验
已完成
不适用
A clinical study in healthy volunteers to determine whether orally consumed tocopheryl phosphates are incorporated into oil produced/secreted by the skin.ACTRN12609000848202Phosphagenics Limited40
已完成
1 期
A phase I study to determine the tolerability and safety of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).To promote pain relief in healthy volunteers.Anaesthesiology - Pain managementACTRN12609000836235Phosphagenics Limited44
已完成
1 期
A Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Forms of PRAX-114.DepressionACTRN12620000522910Praxis Precision Medicines Australia, Pty Ltd85
已完成
1 期
A Phase 1 Study in Healthy Volunteers to Evaluate UDP glucuronosyl transferase (UGT) and Cytochrome (CYP) P450 - Mediated Drug-Drug Interactions Between GS-9688 and Probe DrugsHepatitis BACTRN12617000700336Gilead Sciences, Inc100
已完成
1 期
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food on GS 9688ACTRN12616001646437Gilead Sciences, Inc.102